While homozygous carriers of CFTR mutations generally develop cystic fibrosis, heterozygous carriers do not necessarily; however, they often exhibit an increased risk for pancreatitis and associated pancreatic damage characterized by elevated mucus levels, fibrosis, and cyst formation [61]. This evidence concerns the gene CFTR and cyst.